Cargando…
Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors
BACKGROUND: Type 2 diabetes mellitus and gastroesophageal reflux disease are highly prevalent in the United States. First-line therapies for these disease states include metformin and proton pump inhibitors, respectively. Both of these medications have been associated with a decreased absorption of...
Autores principales: | Chappell, Logan, Brown, Stephen A., Wensel, Terri M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127105/ https://www.ncbi.nlm.nih.gov/pubmed/34007643 http://dx.doi.org/10.24926/iip.v11i4.3355 |
Ejemplares similares
-
Vitamin B(12) Deficiency Associated With Concomitant Metformin and Proton Pump Inhibitor Use
por: Long, Amanda N., et al.
Publicado: (2012) -
Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B(12) Depletion
por: Zdilla, Matthew J.
Publicado: (2015) -
Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013) -
Impact of concomitant proton pump inhibitor during oral anticoagulant treatment
por: Lee, K N, et al.
Publicado: (2023) -
Evaluation of vitamin B12 monitoring in patients on metformin in urban ambulatory care settings
por: Longo, Stacy L., et al.
Publicado: (2019)